Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2018 07:01 ET | Source: Sientra, Inc.

Sientra Commences Public Offering of Common Stock

SANTA BARBARA, Calif., April 30, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that it has commenced an...
April 25, 2018 08:30 ET | Source: Sientra, Inc.

Sientra to Showcase OPUS™ Breast Products and miraDry fresh™ Procedure at American Society of Aesthetic Plastic Surgeons Meeting

Unveils Sientra Platinum20™ Best in Class Warranty Program for OPUS Breast Implants Announces Preliminary Unaudited First Quarter 2018 Net Sales of Approximately $14.5 Million SANTA BARBARA, Calif.,...
April 18, 2018 16:01 ET | Source: Sientra, Inc.

Sientra Receives FDA Approval of PMA Supplement

Commercial Sale of U.S.-Manufactured OPUS™ Branded Breast Implants to Begin Immediately Additional $10 Million of Existing Credit Facility Now Accessible with FDA Approval SANTA BARBARA, Calif.,...
March 13, 2018 16:01 ET | Source: Sientra, Inc.

Sientra Reports Fourth Quarter and Full Year 2017 Financial Results

Remains on Track for Full and Final FDA Approval for U.S. Manufactured Implants Received ISO 13485 Certification for Breast Implants and Tissue Expanders Advanced miraDry Integration and...
March 02, 2018 16:01 ET | Source: Sientra, Inc.

Sientra® to Release Fourth Quarter and Full Year 2017 Financial Results on Tuesday, March 13, 2017

SANTA BARBARA, Calif., March 02, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company (“Sientra or the “Company”), announced today that the Company will release its...
February 16, 2018 08:30 ET | Source: Sientra, Inc.

Sientra Launches New miraDry fresh™ Protocol for the miraDry® System at American Academy of Dermatology Annual Meeting

SANTA BARBARA, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- miraDry, Inc., a subsidiary of Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced the...
January 30, 2018 16:01 ET | Source: Sientra, Inc.

Sientra® Provides Update on FDA Review of U.S. Manufacturing Facility

SANTA BARBARA, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today provided an update on its pre-market approval...
January 25, 2018 16:01 ET | Source: Sientra, Inc.

Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SANTA BARBARA, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on January 19, 2018, the...
January 08, 2018 08:00 ET | Source: Sientra, Inc.

Sientra Announces Preliminary Unaudited Fourth Quarter 2017 Revenue

Board Member Keith Sullivan Appointed Interim General Manager of miraDry Miramar Labs Officially Named miraDry, a Sientra Subsidiary Universal Shelf Registration Filed on Form S-3 SANTA BARBARA,...
November 07, 2017 16:01 ET | Source: Sientra, Inc.

Sientra Reports Third Quarter 2017 Financial Results

Completed FDA Facility Inspection Completed Acquisition of Miramar Labs and Making Significant Progress with Integration SANTA BARBARA, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sientra, Inc....